About NeuroEM

Our mission


At NeuroEM Therapeutics®, our mission is to revolutionize the drug-free treatment of cognitive decline through our groundbreaking Transcranial Electromagnetic Treatment, leveraging Radio Frequencies (TEMT-RF) technology. We are dedicated to translating over a decade of rigorous clinical research to develop safe, effective, and non-invasive solutions that stop and even reverse cognitive deterioration, offering hope to millions affected by neurodegenerative diseases like Alzheimer’s and those striving to maintain cognitive health throughout the aging process.

First-in-class device designed to fight Alzheimer’s


NeuroEM Therapeutics’ “first-in-class” MemorEM™ device was designed to be comfortably worn on the head to administer TEMT-RF during daily in-home treatment.

Our pioneering TEMT-RF technology has shown extraordinary promise against Alzheimer’s in all completed preclinical and clinical studies.

The electromagnetic waves emanating from multiple emitters in the wearable head cap disaggregate toxic protein ‘oligomers’ within neurons throughout the brain. Since these oligomers are increasingly believed to be the root cause of Alzheimer’s disease, we believe the MemorEM head device will directly attack the Alzheimer’s disease process.

TEMT-RF has two additional mechanisms of action that attack Alzheimer’s and other causes of cognitive decline – TEMT-RF re-balances the immune system in both brain and blood and TEMT-RF increases the energy production of brain cells.

NeuroEM’s MemorEM device will be available through neurologists and other health professionals who diagnose memory disorders once we complete our pivotal trials and receive FDA approval.

Read the NeuroEM Story

Leadership Team


  • Rob Baranowski

    Rob Baranowski

    Sr. Engineer
    Product Development

    Bio
  • Chuanhai Cao, MPH, PhD

    Chuanhai Cao, MPH, PhD

    Head of USF Research Team

    Bio
  • Edward Goodwin, PhD

    Edward Goodwin, PhD

    Chief Scientist

    Bio
  • Tracy Ingram

    Tracy Ingram

    Chief Information Officer

    Bio
  • Patty Meagher

    Patty Meagher

    Community Advocate

    Bio
  • Chuck Papageorgiou

    Chuck Papageorgiou

    Chief Executive Officer

    Bio
  • Amanda Patanow

    Amanda Patanow

    Chief Product
    & Marketing Officer

    Bio
  • Marilyn Thompson

    Marilyn Thompson

    Chief Financial Officer

    Bio

Advisors


  • Gary Arendash, PhD

    Gary Arendash, PhD

    Founder
    & Scientist Emeritus

    Bio
  • William Scott Burgin, MD

    William Scott Burgin, MD

    Medical Advisor

    Bio
  • Stephen Hull, MHS

    Stephen Hull, MHS

    Reimbursement Advisor

    Bio
  • Kim H. Manwaring, MD

    Kim H. Manwaring, MD

    Medical Advisor

    Bio
  • Lloyd Marks, MD, MBA, FACC

    Lloyd Marks, MD, MBA, FACC

    Medical Advisor

    Bio
  • Christopher Rumana, MD

    Christopher Rumana, MD

    Medical Advisor

    Bio
  • Johana Carolina Marisol Vega Leonel, PhD

    Johana Carolina Marisol Vega Leonel, PhD

    Medical Advisor

    Bio

Directors


  • Jonathan Gordon

    Jonathan Gordon

    Chairman of the Board

    Bio
  • Mitch Lairmore, MBA

    Mitch Lairmore, MBA

    Director
    & Proxy for Dr. Arendash

    Bio
  • Jamie Rutledge

    Jamie Rutledge

    Director

    Bio

Partners and Collaborators


  • Left Coast Engineering

  • RF Exposure Lab

  • Ocotillo Electromagnetics

  • Remarkable Technologies

  • USF Health/Byrd Alzheimer’s Institute

  • Axiom Clinical Research of Florida

  • Invicro/Konica Minolta

  • MegaNano Biotech Inc.

  • University of South Florida